<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Marts 2022]]></title><description><![CDATA[<p dir="auto">Novo/Citi: Anbefalingen løftes til "køb" fra "neutral" <a href="https://proinvestor.com/investornyt/789544/novo-citi-anbefalingen-loftes-til-kob-fra-neutral" rel="nofollow ugc">https://proinvestor.com/investornyt/789544/novo-citi-anbefalingen-loftes-til-kob-fra-neutral</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400860/pharma-marts-2022</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 07:39:15 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400860.rss" rel="self" type="application/rss+xml"/><pubDate>Wed, 02 Mar 2022 04:56:24 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 30 Mar 2022 07:56:54 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck indgår licensaftale for antidepressiv i Indien <a href="https://proinvestor.com/investornyt/802169/lundbeck-indgar-licensaftale-for-antidepressiv-i-indien" rel="nofollow ugc">https://proinvestor.com/investornyt/802169/lundbeck-indgar-licensaftale-for-antidepressiv-i-indien</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037589</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037589</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 30 Mar 2022 07:56:54 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 24 Mar 2022 13:17:49 GMT]]></title><description><![CDATA[<p dir="auto">Novo/CEO: Har sikret medicin i to måneder til patienter i Ukraine <a href="https://proinvestor.com/investornyt/799863/novo-ceo-har-sikret-medicin-i-to-maneder-til-patienter-i-ukraine" rel="nofollow ugc">https://proinvestor.com/investornyt/799863/novo-ceo-har-sikret-medicin-i-to-maneder-til-patienter-i-ukraine</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037586</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037586</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 24 Mar 2022 13:17:49 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 23 Mar 2022 11:48:01 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck: Aktionærforening vil have mere ambitiøse vækstplaner - NY <a href="https://proinvestor.com/investornyt/799218/lundbeck-aktionaerforening-vil-have-mere-ambitiose-vaekstplaner-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/799218/lundbeck-aktionaerforening-vil-have-mere-ambitiose-vaekstplaner-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037587</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037587</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Mar 2022 11:48:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 23 Mar 2022 11:30:01 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck har stoppet studier i Rusland - men leverer stadig medicin <a href="https://proinvestor.com/investornyt/799118/lundbeck-har-stoppet-studier-i-rusland-men-leverer-stadig-medicin" rel="nofollow ugc">https://proinvestor.com/investornyt/799118/lundbeck-har-stoppet-studier-i-rusland-men-leverer-stadig-medicin</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037584</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037584</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Mar 2022 11:30:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 16 Mar 2022 06:39:18 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Deutsche: Løfter til "køb" - NY <a href="https://proinvestor.com/investornyt/795942/novo-deutsche-lofter-til-kob-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/795942/novo-deutsche-lofter-til-kob-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037585</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037585</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 16 Mar 2022 06:39:18 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Tue, 08 Mar 2022 04:52:37 GMT]]></title><description><![CDATA[<p dir="auto">Novo anlægger patentsag i USA - vil forhindre kopier af Ozempic - GENT <a href="https://proinvestor.com/investornyt/792076/novo-anlaegger-patentsag-i-usa-vil-forhindre-kopier-af-ozempic-gent" rel="nofollow ugc">https://proinvestor.com/investornyt/792076/novo-anlaegger-patentsag-i-usa-vil-forhindre-kopier-af-ozempic-gent</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037590</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037590</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 08 Mar 2022 04:52:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 03 Mar 2022 11:39:14 GMT]]></title><description><![CDATA[<p dir="auto">Novo/dir: Mere end fordobler mål for fedme til over 25 mia kr i 25-NY2 <a href="https://proinvestor.com/investornyt/790196/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny2" rel="nofollow ugc">https://proinvestor.com/investornyt/790196/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny2</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037588</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037588</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Mar 2022 11:39:14 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 03 Mar 2022 11:37:37 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Fase 3-data fra ugentligt insulin på vej om et par måneder <a href="https://proinvestor.com/investornyt/790225/novo-fase-3-data-fra-ugentligt-insulin-pa-vej-om-et-par-maneder" rel="nofollow ugc">https://proinvestor.com/investornyt/790225/novo-fase-3-data-fra-ugentligt-insulin-pa-vej-om-et-par-maneder</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037580</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037580</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Mar 2022 11:37:37 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 03 Mar 2022 10:51:16 GMT]]></title><description><![CDATA[<p dir="auto">Novo/dir: Mere end fordobler mål for fedme til over 25 mia kr i 25 -NY <a href="https://proinvestor.com/investornyt/790183/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/790183/novo-dir-mere-end-fordobler-mal-for-fedme-til-over-25-mia-kr-i-25-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037581</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037581</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Mar 2022 10:51:16 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 03 Mar 2022 08:39:38 GMT]]></title><description><![CDATA[<p dir="auto">Novo/dir: Går efter tre nye lægemiddelkandidater årligt fra Dicerna <a href="https://proinvestor.com/investornyt/790126/novo-dir-gar-efter-tre-nye-laegemiddelkandidater-arligt-fra-dicerna" rel="nofollow ugc">https://proinvestor.com/investornyt/790126/novo-dir-gar-efter-tre-nye-laegemiddelkandidater-arligt-fra-dicerna</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037582</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037582</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Mar 2022 08:39:38 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Thu, 03 Mar 2022 08:01:15 GMT]]></title><description><![CDATA[<p dir="auto">Novo/CEO: Vi er opmuntrede over vækstmomentum <a href="https://proinvestor.com/investornyt/790122/novo-ceo-vi-er-opmuntrede-over-vaekstmomentum" rel="nofollow ugc">https://proinvestor.com/investornyt/790122/novo-ceo-vi-er-opmuntrede-over-vaekstmomentum</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037583</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037583</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 03 Mar 2022 08:01:15 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 02 Mar 2022 07:19:47 GMT]]></title><description><![CDATA[<p dir="auto">Novo/Sydbank: Bidens forslag om prisloft skaber næppe kursuro <a href="https://proinvestor.com/investornyt/789571/novo-sydbank-bidens-forslag-om-prisloft-skaber-naeppe-kursuro" rel="nofollow ugc">https://proinvestor.com/investornyt/789571/novo-sydbank-bidens-forslag-om-prisloft-skaber-naeppe-kursuro</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037579</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037579</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 02 Mar 2022 07:19:47 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Marts 2022 on Wed, 02 Mar 2022 06:39:02 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Biden vil sænke prisen på receptpligtig medicin i USA - NY <a href="https://proinvestor.com/investornyt/789562/novo-biden-vil-saenke-prisen-pa-receptpligtig-medicin-i-usa-ny" rel="nofollow ugc">https://proinvestor.com/investornyt/789562/novo-biden-vil-saenke-prisen-pa-receptpligtig-medicin-i-usa-ny</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8037578</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8037578</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 02 Mar 2022 06:39:02 GMT</pubDate></item></channel></rss>